Both in Pharmaceuticals
Assembly Biosciences vs Altimmune
Over the past year ASMB returned −35.4% and ALT returned −48.5%; their daily moves had a correlation of 0.23.
ASMB −35.4% ALT −48.5%Growth of $1, one year, split-adjusted
| Metric | ASMB | ALT |
|---|---|---|
| Price | $20.13 | $2.04 |
| Market cap | $409.9M | $396.8M |
| Today | −3.50% | −4.67% |
| 1 month | −12.4% | −26.1% |
| 6 months | −26.5% | −27.7% |
| Year to date | −40.8% | −43.5% |
| 1 year | −35.0% | −49.0% |
| Revenue growth (YoY) | +38.9% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −28.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.5× | 12,800.5× |
| Net cash | $320.4M | $291.5M |
| Dividend yield | — | — |
| Volatility (60d) | 63.4% | 47.2% |
| Short % of float | 28.0% | 22.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).